Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ellagic Acid, Urolithin and Colonic Microbial Communities Affected by Walnut Consumption

NCT04066816 is registered in ClinicalTrials.gov with UConn Health as lead sponsor.

NCT NCT04066816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04066816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ellagic Acid, Urolithin and Colonic Microbial Communities Affected by Walnut Consumption
Lead sponsor
UConn Health
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2019
Completion date
April 8, 2021
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, colon cancer, diet habit